Investor relations pageIR page | no data available |
Founding year | no data available |
Headquarter | , , no data available |
Employees | 154 (as per Q2 2016)no data available |
Sector | Biotechnology, HealthcareBiotechnology, Healthcareno data available |
Ticker | SRNEno data available |
Financial year endsFY ends | End of Decemberno data available |
Last Closing Price as per Oct 13, 2017, in USD |
3.30n/a |
Market Capitalisation in million USD |
190n/a |
Enterprise Value in million USD |
125n/a |
Common Shares Outstanding as per Aug 2, 2016 |
57,570,468n/a |
Preferred Shares Outstanding as per Aug 2, 2016 |
n/a |
Average Basic Shares Outstanding TTM |
39,892,750n/a |
Average Diluted Shares Outstanding TTM |
n/a |
Index Membership |
, US 3000
n/a
|
Revenues | 4n/a |
Gross Profit | 3n/a |
Operating Income | -124n/a |
EBITDA | 0n/a |
Net Profit | -88n/a |
Cash and Cash Equivalents | 67n/a |
Receivables | 0n/a |
Total Current Assets | 72n/a |
PP&E | 7n/a |
Total Assets | 274n/a |
Accounts Payable | 3n/a |
Current Debt | 5n/a |
Total Current Liabilities | 28n/a |
Long-Term Debt | 3n/a |
Total Liabilities | 185n/a |
Total Equity | 89n/a |
Depreciation & Amortisation | 0n/a |
Change in Working Capital | 0n/a |
Operating Cash Flow | 0n/a |
Net Change in PP&E and Intangibles | 0n/a |
Investing Cash Flow | 0n/a |
Dividends Paid | 0n/a |
Financing Cash Flow | 0n/a |
Total Change in Cash | 0n/a |
Free Cash Flow | 0n/a |
Gross Margin | 58.9%n/a |
Operating Margin | -2,862.8%n/a |
Net Profit Margin | -2,189.8%n/a |
Return on Equity | 0.0%n/a |
Return on Assets | 0.0%n/a |
Basic EPS | -2.20n/a |
Diluted EPS | n/a |
Sales per Share | 0.11n/a |
Book Value per Share | n/a |
FCF per Share | n/a |
Dividends per Share | n/a |
Price to Earnings Ratio | -1.50n/a |
Price to Sales Ratio | 30.40n/a |
Price to Book Value | n/a |
Price to Free Cash Flow | n/a |
EV/EBITDA | n/a |
EV/Sales | n/a |
Book to Market Value | 0.47n/a |
Current Ratio | 252.3%n/a |
Liabilities to Equity Ratio | 207.7%n/a |
Debt to Assets Ratio | 2.9%n/a |
in million USD | FY '10 | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 |
---|---|---|---|---|---|---|
|
1
|
1
|
1
|
0
|
4
|
5
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
-2
|
-2
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
1
|
1
|
0
|
2
|
3
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-2
|
-4
|
-5
|
-21
|
-34
|
-75
|
|
-1
|
-1
|
-2
|
-6
|
-10
|
-20
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-1
|
-3
|
-4
|
-15
|
-24
|
-55
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-2
|
-3
|
-5
|
-21
|
-32
|
-73
|
|
0
|
0
|
0
|
0
|
-2
|
-2
|
|
0
|
0
|
0
|
0
|
-2
|
-2
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-2
|
-3
|
-5
|
-21
|
-34
|
-74
|
|
0
|
0
|
0
|
-1
|
-2
|
61
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-2
|
-3
|
-5
|
-22
|
-36
|
-14
|
|
0
|
0
|
0
|
0
|
2
|
-36
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-2
|
-3
|
-5
|
-22
|
-35
|
-50
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-2
|
-3
|
-5
|
-22
|
-35
|
-50
|
|
0
|
0
|
0
|
0
|
0
|
4
|
|
-2
|
-3
|
-5
|
-22
|
-35
|
-46
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-2
|
-3
|
-5
|
-22
|
-35
|
-46
|
Remarks |
restated on Mar 30, 2012
n/a
calculated values,
|
restated on Mar 27, 2013
n/a
calculated values,
|
restated on Mar 16, 2015
n/a
calculated values,
|
restated on Mar 15, 2016
n/a
calculated values,
|
restated on Mar 15, 2016
n/a
calculated values,
|
restated on Mar 15, 2016
n/a
calculated values,
|
in million USD | FY '10 | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 |
---|---|---|---|---|---|---|
Assets | ||||||
|
5
|
3
|
5
|
32
|
72
|
136
|
|
5
|
3
|
5
|
32
|
72
|
39
|
|
0
|
0
|
0
|
0
|
0
|
97
|
|
0
|
0
|
0
|
0
|
1
|
1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
1
|
1
|
4
|
|
0
|
0
|
0
|
1
|
1
|
2
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
2
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
6
|
4
|
5
|
33
|
74
|
141
|
|
0
|
1
|
1
|
2
|
2
|
7
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
10
|
170
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
58
|
55
|
25
|
|
0
|
0
|
0
|
33
|
4
|
4
|
|
0
|
0
|
0
|
24
|
24
|
21
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
27
|
1
|
|
0
|
1
|
2
|
60
|
68
|
203
|
|
6
|
5
|
7
|
93
|
142
|
344
|
Liabilities and owners' equity | ||||||
|
0
403957
|
0
359339
|
1
584173
|
4
4202000
|
4
4348000
|
8
7627000
|
|
0
181799
|
0
224742
|
0
439533
|
2
2153000
|
2
1656000
|
1
1339000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
222158
|
0
134597
|
0
144640
|
2
2049000
|
3
2692000
|
6
6288000
|
|
0
0
|
0
0
|
0
0
|
0
374000
|
3
3316000
|
5
4835000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
1
904000
|
2
1893000
|
18
18411000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
1
904000
|
2
1893000
|
18
18411000
|
|
0
403957
|
0
359339
|
1
584173
|
5
5480000
|
10
9557000
|
31
30873000
|
|
0
0
|
0
0
|
0
0
|
4
4431000
|
9
8830000
|
4
4394000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
200000
|
0
0
|
0
0
|
16
15862000
|
14
14441000
|
167
167314000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
1
1497000
|
1
796000
|
0
12000
|
|
0
200000
|
0
0
|
0
0
|
0
0
|
1
1024000
|
111
110900000
|
|
0
0
|
0
0
|
0
0
|
14
14248000
|
2
1709000
|
49
49341000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
117000
|
11
10912000
|
7
7061000
|
|
0
200000
|
0
0
|
0
0
|
20
20293000
|
23
23271000
|
172
171708000
|
|
1
603957
|
0
359339
|
1
584173
|
26
25773000
|
33
32828000
|
203
202581000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
8
7952324
|
10
10314480
|
17
17147730
|
100
99670000
|
176
176231000
|
185
184902000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
-3
-2868500
|
-6
-6104991
|
-11
-10950299
|
-33
-32861000
|
-68
-67518000
|
-113
-113329000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
74
73579000
|
|
5
5083824
|
4
4209489
|
6
6197431
|
67
66809000
|
109
108713000
|
145
145152000
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
-4
-4214000
|
|
5
5083824
|
4
4209489
|
6
6197431
|
67
66809000
|
109
108713000
|
141
140938000
|
|
6
5687781
|
5
4568828
|
7
6781604
|
93
92582000
|
142
141541000
|
344
343519000
|
Remarks | restated on Mar 30, 2012 n/a | restated on Mar 27, 2013 n/a | restated on Apr 1, 2014 n/a | restated on Mar 16, 2015 n/a | restated on Mar 15, 2016 n/a | restated on Aug 8, 2016 n/a |
in million USD | FY '10 | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 |
---|---|---|---|---|---|---|
|
-2
|
-3
|
-5
|
-22
|
-35
|
-50
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
1
|
3
|
2
|
|
0
|
0
|
1
|
4
|
3
|
-9
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
15
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-2
|
-3
|
-4
|
-16
|
-29
|
-42
|
|
0
|
-1
|
-1
|
-1
|
-1
|
-4
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
-10
|
-12
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
-1
|
-1
|
-1
|
-11
|
-15
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
7
|
8
|
-3
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3
|
2
|
6
|
38
|
72
|
2
|
|
3
|
2
|
6
|
38
|
72
|
2
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
-1
|
0
|
-2
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3
|
2
|
6
|
44
|
80
|
-3
|
|
2
|
-2
|
2
|
27
|
40
|
-61
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
2
|
-2
|
2
|
27
|
40
|
-61
|
|
0
|
0
|
0
|
0
|
0
|
0
|
|
2
|
-2
|
2
|
27
|
40
|
-61
|
Remarks |
restated on Mar 30, 2012
n/a
calculated values,
|
restated on Mar 27, 2013
n/a
calculated values,
|
restated on Mar 16, 2015
n/a
calculated values,
|
restated on Mar 15, 2016
n/a
calculated values,
|
restated on Mar 15, 2016
n/a
calculated values,
|
restated on Mar 15, 2016
n/a
calculated values,
|